Mechanisms controlling human microglia gene expression
控制人类小胶质细胞基因表达的机制
基本信息
- 批准号:9271257
- 负责人:
- 金额:$ 38.27万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2016
- 资助国家:美国
- 起止时间:2016-05-15 至 2021-04-30
- 项目状态:已结题
- 来源:
- 关键词:ATAC-seqAdultAtlasesBiological ModelsBrainBrain NeoplasmsCellsChIP-seqCollaborationsControlled EnvironmentDevelopmentDiseaseEnhancersEnvironmentEnvironmental Risk FactorEpigenetic ProcessEpilepsyGene ExpressionGene Expression ProfileGenetic TranscriptionGenetic VariationGenomicsGenotypeGreater sac of peritoneumHealthHomeostasisHumanImmunityIn VitroInfectionInjuryInstitutesLaboratoriesMeasuresMethodsMicrogliaModelingMolecularMouse StrainsMusNeuraxisOperative Surgical ProceduresPatternPeritoneal MacrophagesPhenotypePlayPredictive FactorProcessResectedRoleSamplingSeveritiesSignal TransductionSourceSystems DevelopmentTestingTissuesTransforming Growth Factor betabrain tissueexperimental studygenome-wideinduced pluripotent stem cellinsightinterestloss of functionmacrophagemind controlnervous system disorderpublic health relevancereceptorrepairedresponsetissue culturetranscription factortranscriptometranscriptomics
项目摘要
DESCRIPTION (provided by applicant): Microglia are tissue macrophages that reside in the central nervous system (CNS) and perform unique and critical auxiliary functions important to CNS development, homeostasis, immunity and repair. Despite their importance, remarkably little is known about the mechanisms that control microglia development and function, particularly in humans. Here we propose to leverage recent technical and computational breakthroughs to investigate how interactions between lineage-determining and signal-dependent transcription factors regulate gene expression in human and mouse microglia. Specific Aim 1 will test the hypothesis that the human brain microenvironment is an important determinant of microglia gene expression. Microglia transcriptomes will be obtained immediately upon isolation and after one week in a tissue culture environment supplemented with putative regulators of microglia phenotypes. Importantly, all samples will be analyzed in the context of full genomic sequence. These studies will provide qualitatively new information on core transcriptional signatures of microglia, the influence of the brain microenvironment, and the relationships of genotype to gene expression patterns. Specific Aim 2 will test the hypothesis that PU.1 and a limited set of alternative lineage determining factors drive the selection of the majority of enhancers that determine microglia identity and regulatory potential. We will use ChIP-Seq and ATAC-Seq methods to define enhancer atlases in freshly isolated human microglia. This information will suggest key microglia lineage determining factors and identify microglia super enhancers. We will exploit the combination of ChIP sequencing and natural genetic variation to identify core transcription factor combinations needed for the selection and activation of microglia-specific enhancers. These findings will provide qualitatively new insights into molecular mechanisms that underlie human microglia development and function and will inform efforts to more faithfully reprogram human iPS cells to microglia phenotypes. Specific Aim 3 will test the hypothesis that environmental factors and transcriptional circuits required for
microglia-specific gene expression are conserved between mouse and human. Mouse microglia transcriptomes and enhancer atlases will be obtained under the same conditions as described for human microglia in Specific Aims 1 and 2. Different strains of mice will be used as a source of natural genetic variation to define core transcription factor combinations needed for enhancer selection and activation. Roles of specific transcription factors predicted to have conserved roles
in regulating human and mouse microglia development and function will be assessed by loss of function experiments. These experiments will provide important information on the extent to which mouse microglia can be used to model human microglia and establish the functional importance of conserved transcription factors.
描述(由申请方提供):小胶质细胞是存在于中枢神经系统(CNS)中的组织巨噬细胞,并执行对CNS发育、稳态、免疫和修复至关重要的独特和关键辅助功能。尽管它们很重要,但对控制小胶质细胞发育和功能的机制知之甚少,特别是在人类中。在这里,我们建议利用最近的技术和计算的突破,研究谱系决定和信号依赖性转录因子之间的相互作用如何调节人类和小鼠小胶质细胞的基因表达。具体目标1将测试的假设,人类大脑微环境是一个重要的决定因素的小胶质细胞基因表达。小胶质细胞转录组将在分离后立即获得,并在补充有小胶质细胞表型的推定调节剂的组织培养环境中一周后获得。重要的是,将在全基因组序列的背景下分析所有样品。这些研究将为小胶质细胞的核心转录特征、大脑微环境的影响以及基因型与基因表达模式的关系提供新的定性信息。具体目标2将检验以下假设:PU.1和一组有限的替代谱系决定因子驱动了决定小胶质细胞身份和调控潜力的大多数增强子的选择。我们将使用ChIP-Seq和ATAC-Seq方法来定义新鲜分离的人小胶质细胞中的增强子图谱。这些信息将提示关键的小胶质细胞谱系决定因子,并确定小胶质细胞超级增强子。我们将利用ChIP测序和自然遗传变异的组合来确定选择和激活小胶质细胞特异性增强子所需的核心转录因子组合。这些发现将为人类小胶质细胞发育和功能的分子机制提供定性的新见解,并将为更忠实地将人类iPS细胞重编程为小胶质细胞表型的努力提供信息。具体目标3将测试的假设,环境因素和转录电路所需的
小胶质细胞特异性基因表达在小鼠和人之间是保守的。小鼠小胶质细胞转录组和增强子图谱将在特定目的1和2中针对人小胶质细胞所述的相同条件下获得。不同品系的小鼠将被用作天然遗传变异的来源,以定义增强子选择和激活所需的核心转录因子组合。预测具有保守作用的特定转录因子的作用
在调节人和小鼠小胶质细胞发育和功能方面的作用将通过功能丧失实验来评估。这些实验将提供重要的信息,在何种程度上小鼠小胶质细胞可用于模拟人类小胶质细胞和建立保守的转录因子的功能的重要性。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Christopher K Glass其他文献
Pharmacological correction of a defect in PPAR-γ signaling ameliorates disease severity in Cftr-deficient mice
对 PPAR-γ信号通路缺陷的药理学纠正改善了 Cftr 缺陷小鼠的疾病严重程度
- DOI:
10.1038/nm.2101 - 发表时间:
2010-02-14 - 期刊:
- 影响因子:50.000
- 作者:
Gregory S Harmon;Darren S Dumlao;Damian T Ng;Kim E Barrett;Edward A Dennis;Hui Dong;Christopher K Glass - 通讯作者:
Christopher K Glass
Sterols and oxysterols in immune cell function
免疫细胞功能中的固醇和氧固醇
- DOI:
10.1038/ni.2681 - 发表时间:
2013-08-20 - 期刊:
- 影响因子:27.600
- 作者:
Nathanael J Spann;Christopher K Glass - 通讯作者:
Christopher K Glass
Christopher K Glass的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Christopher K Glass', 18)}}的其他基金
A Cardiovascular-NASH disease nexus: Common Mechanisms and Treatments?
心血管疾病与 NASH 疾病的关系:常见机制和治疗方法?
- 批准号:
10683961 - 财政年份:2020
- 资助金额:
$ 38.27万 - 项目类别:
Macrophage-specific targeting of LXRs in CVD and NASH
CVD 和 NASH 中 LXR 的巨噬细胞特异性靶向
- 批准号:
10262918 - 财政年份:2020
- 资助金额:
$ 38.27万 - 项目类别:
A Cardiovascular-NASH disease nexus: Common Mechanisms and Treatments?
心血管疾病与 NASH 疾病的关系:常见机制和治疗方法?
- 批准号:
10262913 - 财政年份:2020
- 资助金额:
$ 38.27万 - 项目类别:
Macrophage-specific targeting of LXRs in CVD and NASH
CVD 和 NASH 中 LXR 的巨噬细胞特异性靶向
- 批准号:
10461064 - 财政年份:2020
- 资助金额:
$ 38.27万 - 项目类别:
A Cardiovascular-NASH disease nexus: Common Mechanisms and Treatments?
心血管疾病与 NASH 疾病的关系:常见机制和治疗方法?
- 批准号:
10461059 - 财政年份:2020
- 资助金额:
$ 38.27万 - 项目类别:
Macrophage-specific targeting of LXRs in CVD and NASH
CVD 和 NASH 中 LXR 的巨噬细胞特异性靶向
- 批准号:
10683973 - 财政年份:2020
- 资助金额:
$ 38.27万 - 项目类别:
相似海外基金
Co-designing a lifestyle, stop-vaping intervention for ex-smoking, adult vapers (CLOVER study)
为戒烟的成年电子烟使用者共同设计生活方式、戒烟干预措施(CLOVER 研究)
- 批准号:
MR/Z503605/1 - 财政年份:2024
- 资助金额:
$ 38.27万 - 项目类别:
Research Grant
Early Life Antecedents Predicting Adult Daily Affective Reactivity to Stress
早期生活经历预测成人对压力的日常情感反应
- 批准号:
2336167 - 财政年份:2024
- 资助金额:
$ 38.27万 - 项目类别:
Standard Grant
RAPID: Affective Mechanisms of Adjustment in Diverse Emerging Adult Student Communities Before, During, and Beyond the COVID-19 Pandemic
RAPID:COVID-19 大流行之前、期间和之后不同新兴成人学生社区的情感调整机制
- 批准号:
2402691 - 财政年份:2024
- 资助金额:
$ 38.27万 - 项目类别:
Standard Grant
Migrant Youth and the Sociolegal Construction of Child and Adult Categories
流动青年与儿童和成人类别的社会法律建构
- 批准号:
2341428 - 财政年份:2024
- 资助金额:
$ 38.27万 - 项目类别:
Standard Grant
Elucidation of Adult Newt Cells Regulating the ZRS enhancer during Limb Regeneration
阐明成体蝾螈细胞在肢体再生过程中调节 ZRS 增强子
- 批准号:
24K12150 - 财政年份:2024
- 资助金额:
$ 38.27万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Understanding how platelets mediate new neuron formation in the adult brain
了解血小板如何介导成人大脑中新神经元的形成
- 批准号:
DE240100561 - 财政年份:2024
- 资助金额:
$ 38.27万 - 项目类别:
Discovery Early Career Researcher Award
RUI: Evaluation of Neurotrophic-Like properties of Spaetzle-Toll Signaling in the Developing and Adult Cricket CNS
RUI:评估发育中和成年蟋蟀中枢神经系统中 Spaetzle-Toll 信号传导的神经营养样特性
- 批准号:
2230829 - 财政年份:2023
- 资助金额:
$ 38.27万 - 项目类别:
Standard Grant
Usefulness of a question prompt sheet for onco-fertility in adolescent and young adult patients under 25 years old.
问题提示表对于 25 岁以下青少年和年轻成年患者的肿瘤生育力的有用性。
- 批准号:
23K09542 - 财政年份:2023
- 资助金额:
$ 38.27万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Identification of new specific molecules associated with right ventricular dysfunction in adult patients with congenital heart disease
鉴定与成年先天性心脏病患者右心室功能障碍相关的新特异性分子
- 批准号:
23K07552 - 财政年份:2023
- 资助金额:
$ 38.27万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Issue identifications and model developments in transitional care for patients with adult congenital heart disease.
成人先天性心脏病患者过渡护理的问题识别和模型开发。
- 批准号:
23K07559 - 财政年份:2023
- 资助金额:
$ 38.27万 - 项目类别:
Grant-in-Aid for Scientific Research (C)